| Literature DB >> 34327418 |
Hong Lv1,2, Feiyang Diao1,3, Jiangbo Du1, Ting Chen4, Qingxia Meng1,5, Xiufeng Ling1,6, Hong Li1,5, Ci Song1, Qi Xi7, Yangqian Jiang1, Yan Xu8, Shiyao Tao1, Lei Huang1, Mingyang Wen1, Meijuan Peng1, Cong Liu1, Qun Lu1, Yuanlin He1, Yin Yin1,9, Xiaoyu Liu1, Bo Xu1, Xiumei Han1, Kun Zhou1, Tao Jiang1, Yang Zhao1, Hongxia Ma1, Guangfu Jin1, Yankai Xia1,10, Jiayin Liu1,2,3, Yuan Lin1,2,11, Zhibin Hu1,2, Hongbing Shen1,2.
Abstract
BACKGROUND: It has been consistently shown in several meta-analyses that infants born after ART have an excess of birth defects compared with those after spontaneous conception, however, the prevalence of birth defects among ART offspring in China is incompletely studied. Moreover, it is unclear to what extent the risk of birth defects is associated with parental infertility characteristics, specific ART procedures and twinning.Entities:
Year: 2021 PMID: 34327418 PMCID: PMC8315325 DOI: 10.1016/j.lanwpc.2020.100090
Source DB: PubMed Journal: Lancet Reg Health West Pac ISSN: 2666-6065
Characteristics of 1790 women who conceived by ART and 3400 women who conceived spontaneously.
| Characteristicsa | ART-conception group ( | Spontaneous-conception group ( |
|---|---|---|
| Maternal age, year, No. (%) | ||
| <35 | 1447 (80•8) | 2952 (86•8) |
| ≥35 | 343 (19•2) | 448 (13•2) |
| Parity, No. (%) | ||
| Nulliparous | 1615 (90•2) | 2254 (66•3) |
| Multiparous | 175 (9•8) | 1145 (33•7) |
| Plurality, No. (%) | ||
| Singleton | 1349 (75•4) | 3367 (99•0) |
| Twins | 441 (24•6) | 33 (1•0) |
| Maternal pre-pregnancy BMI, kg/m2, No. (%) | ||
| <18•5 | 148 (8•3) | 465 (13•7) |
| 18•5–23•9 | 1185 (66•2) | 2284 (67•2) |
| 24–27•9 | 360 (20•1) | 411 (12•1) |
| ≥28 | 97 (5•4) | 87 (2•6) |
| Household income, CNY, No. (%) | ||
| <50,000 | 107 (6•0) | 135 (4•0) |
| 50,000–100,000 | 564 (31•5) | 638 (18•8) |
| 100,000–200,000 | 655 (36•6) | 1482 (43•6) |
| ≥200,000 | 464 (25•9) | 1110 (32•6) |
| Maternal education, year, No. (%) | ||
| <12 | 526 (29•4) | 335 (9•9) |
| ≥12 | 1264 (70•6) | 2937 (86•4) |
| Tobacco use during pregnancy, No. (%) | 1 (0•1) | 12 (0•4) |
| Alcohol intake during pregnancy, No. (%) | 5 (0•3) | 59 (1•7) |
| Diseases during pregnancy | ||
| Diabetes, No. (%)b | 502 (28•0) | 781 (23•0) |
| Hypertension, No. (%)c | 172 (9•6) | 97 (2•9) |
Abbreviation: ART, assisted reproductive technology; BMI, body mass index; CNY, China yuan.
a Missing data less than 5% for parity, maternal pre-pregnancy BMI, household income, maternal education, tobacco use during pregnancy, alcohol intake during pregnancy, diabetes and hypertension during pregnancy. No missing for maternal age and plurality.
b Includes chronic and gestational diabetes.
c Includes chronic and pregnancy-induced hypertension.
Cumulative prevalence of birth defects according to age at diagnosis and plurality.
| Age at diagnosis | ART-conceived | Spontaneous-conceived | Crude RR (95%CI) | aRR (95%CI)a | ||
|---|---|---|---|---|---|---|
| No. of birth | No. of birth defects (%) | No. of birth | No. of birth defects (%) | |||
| All Births | ||||||
| Prenatal | 2231 | 50 (2•2) | 3433 | 42 (1•2) | 1•89 (1•24–2•86) | 2•10 (1•23–3•59) |
| By 7 days after delivery | 2231 | 109 (4•9) | 3433 | 100 (2•9) | 1•74 (1•31–2•31) | 1•63 (1•16–2•28) |
| By 6 months after delivery | 1921 | 200 (10•4) | 3118 | 164 (5•3) | 2•09 (1•67–2•62) | 1•95 (1•50–2•54) |
| By 1 year after delivery | 1566 | 217 (13•9) | 2768 | 194 (7•0) | 2•17 (1•75–2•69) | 1•99 (1•55–2•56) |
| Singleton Births | ||||||
| Prenatal | 1349 | 42 (3•1) | 3367 | 40 (1•2) | 2•74 (1•77–4•25) | 2•97 (1•67–5•29) |
| By 7 days after delivery | 1349 | 73 (5•4) | 3367 | 95 (2•8) | 1•99 (1•46–2•72) | 1•82 (1•25–2•65) |
| By 6 months after delivery | 1118 | 107 (9•6) | 3059 | 153 (5•0) | 2•02 (1•56–2•61) | 1•88 (1•38–2•55) |
| By 1 year after delivery | 873 | 112 (12•8) | 2713 | 182 (6•7) | 2•05 (1•60–2•63) | 1•85 (1•38–2•48) |
| Twins | ||||||
| Prenatal | 882 | 8 (0•9) | 66 | 2 (3•0) | 0•29 (0•06–1•43) | 0•24 (0•06–1•03) |
| By 7 days after delivery | 882 | 36 (4•1) | 66 | 5 (7•6) | 0•52 (0•17–1•60) | 0•50 (0•13–1•92) |
| By 6 months after delivery | 803 | 93 (11•6) | 59 | 11 (18•6) | 0•56 (0•24–1•29) | 0•45 (0•18–1•10) |
| By 1 year after delivery | 693 | 105 (15•2) | 55 | 12 (21•8) | 0•64 (0•28–1•50) | 0•51 (0•20–1•31) |
a Analyses were adjusted for maternal age, parity, maternal pre-pregnancy BMI, diabetes and hypertension.
Fig. 1Cumulative prevalence of birth defects according to age at diagnosis.
Association between ART characteristics and birth defects among ART-conceived births.
| Characteristics | Levels | No. of birth | No. of birth defects (%) | aRR (95%CI)a | |
|---|---|---|---|---|---|
| Infertility Diagnosis | |||||
| Duration of infertility, month | <36 | 753 | 105 (13•9) | 1•00 | |
| ≥36 | 799 | 112 (14•0) | 1•06 (0•77–1•46) | 0•728 | |
| PCOS | No | 1368 | 193 (14•1) | 1•00 | |
| Yes | 184 | 24 (13•0) | 0•91 (0•53–1•56) | 0•728 | |
| Ovarian dysfunction | No | 1404 | 189 (13•5) | 1•00 | |
| Yes | 148 | 28 (18•9) | 1•52 (0•93–2•50) | 0•095 | |
| Endometriosis | No | 1441 | 209 (14•5) | 1•00 | |
| Yes | 111 | 8 (7•2) | 0•45 (0•22–0•95) | 0•037 | |
| Pelvic or tubal factor | No | 344 | 49 (14•2) | 1•00 | |
| Yes | 1208 | 168 (13•9) | 0•96 (0•66–1•38) | 0•814 | |
| Uterine factor | No | 1061 | 152 (14•3) | 1•00 | |
| Yes | 491 | 65 (13•2) | 0•85 (0•60–1•20) | 0•347 | |
| Thyroid factor | No | 1492 | 205 (13•7) | 1•00 | |
| Yes | 60 | 12 (20•0) | 1•74 (0•87–3•48) | 0•115 | |
| Sperm disorder | No | 622 | 100 (16•1) | 1•00 | |
| Yes | 930 | 117 (12•6) | 0•84 (0•61–1•15) | 0•275 | |
| ART Procedure | |||||
| Cycle type | Fresh | 295 | 38 (12•9) | 1•00 | |
| Frozen | 1257 | 179 (14•2) | 1•07 (0•71–1•61) | 0•756 | |
| Number of embryos transferred | One | 367 | 57 (15•5) | 1•00 | |
| Two or more | 1185 | 160 (13•5) | 0•87 (0•62–1•22) | 0•427 | |
| Stage of embryo transferred | Cleavage | 671 | 82 (12•2) | 1•00 | |
| Blastocyst | 881 | 135 (15•3) | 1•17 (0•85–1•62) | 0•327 | |
| Fertilization method | IVF | 1143 | 162 (14•2) | 1•00 | |
| ICSI | 395 | 55 (13•9) | 0•98 (0•69–1•41) | 0•934 | |
| PGD | No | 1521 | 215 (14•1) | 1•00 | |
| Yes | 31 | 2 (6•5) | 0•38 (0•09–1•61) | 0•187 | |
| Assisted hatching | No | 466 | 52 (11•2) | 1•00 | |
| Yes | 1086 | 165 (15•2) | 1•26 (0•88–1•82) | 0•208 | |
| Regimen of ovulation induction | GnRH-a | 712 | 80 (11•2) | 1•00 | |
| GnRHant | 750 | 119 (15•9) | 1•48 (1•05–2•09) | 0•024 | |
| Microstimulation | 90 | 18 (20•0) | 2•11 (1•13–3•93) | 0•019 | |
| Medication Usage | |||||
| GnRH agonist doses | – | 1552 | 217 (14•0) | 0•91 (0•79–1•05) | 0•176 |
| GnRHant doses | – | 1552 | 217 (14•0) | 1•13 (0•87–1•47) | 0•351 |
| Gn doses, per 1000IU | – | 1552 | 217 (14•0) | 1•01 (0•78–1•31) | 0•956 |
| Gn type | FSH only | 767 | 107 (14•0) | 1•00 | |
| FSH+LH | 126 | 17 (13•5) | 0•88 (0•48–1•62) | 0•685 | |
| hMG | 656 | 92 (14•0) | 1•10 (0•79–1•53) | 0•581 | |
| Clomiphene | No | 1494 | 205 (13•7) | 1•00 | |
| Yes | 58 | 12 (20•7) | 1•65 (0•83–3•26) | 0•153 | |
| Growth hormone | No | 1483 | 202 (13•6) | 1•00 | |
| Yes | 69 | 15 (21•7) | 1•71 (0•88–3•33) | 0•117 |
Abbreviation: PCOS, polycystic ovary syndrome; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; PGD, preimplantation genetic diagnosis; GnRH-a, gonadotropin-releasing hormone agonist; GnRHant, gonadotropin-releasing hormone antagonist; Gn, gonadotropin; FSH, follicle stimulating hormone; LH, luteinizing hormone; hMG, human chorionic gonadotropin.
a Analyses were adjusted for maternal age, parity, maternal pre-pregnancy BMI, diabetes and hypertension.
Multivariable logistic regression analysis of ART characteristics on birth defects among ART-conceived births.
| Characteristics | Levels | No. of birth | No. of birth defects (%) | aRR (95%CI) | |
|---|---|---|---|---|---|
| Maternal age, year | – | 1552 | 217 (14•0) | 1•01 (0•96–1•05) | 0•776 |
| Parity | Nulliparous | 1394 | 194 (13•9) | 1•00 | |
| Multiparous | 158 | 23 (14•6) | 1•03 (0•59–1•80) | 0•907 | |
| Maternal pre-pregnancy BMI, kg/m2 | – | 1552 | 217 (14•0) | 0•99 (0•94–1•04) | 0•764 |
| Diabetes | No | 1062 | 153 (14•4) | 1•00 | |
| Yes | 435 | 62 (14•3) | 0•97 (0•67–1•39) | 0•850 | |
| Hypertension | No | 1322 | 187 (14•1) | 1•00 | |
| Yes | 170 | 27 (15•9) | 1•07 (0•65–1•76) | 0•804 | |
| Ovarian dysfunction | No | 1404 | 189 (13•5) | 1•00 | |
| Yes | 148 | 28 (18•9) | 1•22 (0•66–2•25) | 0•528 | |
| Regimen of ovulation induction | GnRH-a | 712 | 80 (11•2) | 1•00 | |
| GnRHant | 750 | 119 (15•9) | 1•47 (1•04–2•07) | 0•029 | |
| Microstimulation | 90 | 18 (20•0) | 1•85 (0•86–3•99) | 0•117 |
Fig. 2Analysis of assisted reproductive technology and birth defects association with twin pregnancy as a mediator.